INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 204 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2015. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $704,000 | +28.0% | 5,481 | +49.6% | 0.00% | 0.0% |
| Q4 2015 | $550,000 | -5.7% | 3,663 | +4.2% | 0.00% | 0.0% |
| Q3 2015 | $583,000 | -18.2% | 3,516 | +19.1% | 0.00% | 0.0% |
| Q2 2015 | $713,000 | -92.8% | 2,953 | -91.6% | 0.00% | -94.4% |
| Q1 2015 | $9,938,000 | -36.8% | 35,237 | -65.0% | 0.02% | -35.7% |
| Q4 2014 | $15,729,000 | -16.9% | 100,754 | +26.0% | 0.03% | -17.6% |
| Q3 2014 | $18,926,000 | +74.1% | 79,960 | +70.8% | 0.03% | +78.9% |
| Q2 2014 | $10,872,000 | +71.7% | 46,810 | +107.6% | 0.02% | +72.7% |
| Q1 2014 | $6,331,000 | +12.5% | 22,545 | +9.8% | 0.01% | +10.0% |
| Q4 2013 | $5,629,000 | +287.4% | 20,542 | -2.4% | 0.01% | +233.3% |
| Q3 2013 | $1,453,000 | – | 21,049 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |